Coronavirus membrane fusion mechanism offers a potential target for antiviral development

Area of Science:

• Virology
• Antiviral Drug Discovery
• Molecular Biology

Background:

• The COVID-19 pandemic highlights the urgent need for effective therapies against SARS-CoV-2 and other pathogenic coronaviruses (CoVs).
• Coronaviruses pose a significant threat due to their potential for emergence and re-emergence.
• Understanding CoV replication is key to developing novel antiviral strategies.

Purpose of the Study:

• To review the role of the CoV spike protein in viral and host cell membrane fusion.
• To identify the conserved fusion mechanism as a potential target for broad-spectrum antiviral agents.
• To summarize research on SARS-CoV, MERS-CoV, and SARS-CoV-2 spike protein function.

Main Methods:

• Literature review of peer-reviewed studies on coronavirus spike proteins and membrane fusion.
• Analysis of conserved fusion mechanisms across different CoV species.
• Compilation of background information on human-infecting coronaviruses and their phylogeny.

Main Results:

• The CoV spike protein is essential for mediating viral and host cell membrane fusion.
• The fusion domain and mechanism are conserved across the CoV family, indicating a common vulnerability.
• Research on SARS-CoV, MERS-CoV, and SARS-CoV-2 demonstrates the critical role of spike-mediated fusion.

Conclusions:

• The conserved CoV fusion mechanism represents a promising target for developing pan-coronavirus antiviral therapies.
• Investigating this mechanism can lead to broad-spectrum agents effective against current and future CoV threats.
• Further research into spike protein-mediated fusion is warranted for therapeutic development.